Company page

Newron Pharmaceuticals S.p.a.

Newron Pharmaceuticals S.p.A. is a public company listed on the Swiss market under the ticker NWRN, with a market capitalization of approximately 300.5 million Swiss francs. The company focuses on developing innovative treatments for patients with neurological diseases. Newron is committed to advancing its pipeline of therapies to address unmet medical needs in this specialized field.